Ursprung des Netzwerks ersten Grades von W. Shawn Carbonell
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
OncoSynergy, Inc.
 OncoSynergy, Inc. Pharmaceuticals: MajorHealth Technology OncoSynergy, Inc. engages in the provision of solutions for treatment-resistant cancer. It develops new class of oncology therapeutics, called Resistance Mechanism Inhibitors (RMIs), it is a multi-action, tumor-agnostic drug platforms that have shown preclinical promise as monotherapy and in strategic combinations. The company was founded by Shawn W. Carbonell, Anne-Marie Carbonell, and Catherine Park in 2011 and is headquartered in Greenwich, CT.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von W. Shawn Carbonell
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|
Statistik
International
Sektoral
Operativ
| Founder | 2 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Catherine Park | 1 |
| Anne-Marie Carbonell | 1 |
| Ambar Picon | 1 |
- Börse
- Insiders
- W. Shawn Carbonell
- Unternehmensverbindungen
